Pathogen‐reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions
Open Access
- 27 August 2021
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 61 (10) , 2869-2876
Abstract
Background: Pathogen‐reduced platelets (PR PLT) are the emerging standard for proactive transfusion‐transmitted infection (TTI) mitigation. There is, however, continued hesitation to transfuse PR PLT in children due to limited published data. We report demographics, rates of transfusion, and transfusion reactions (TR) associated with FDA‐approved PR PLT in pediatric and neonatal patients at an academic medical center.Methods: Retrospective review was performed for patients p = .7052). Of 51 neonates, 37 received PR PLT without adverse events, including 13 receiving phototherapy. No TTIs were identified in any group.Conclusion: There was no significant difference in rates of transfusion or TRs between PR and CONV PLT. Our study provides additional evidence that PR PLT can be transfused to pediatric and neonatal patients without increasing the risk of acute adverse events.Keywords
This publication has 31 references indexed in Scilit:
- Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributesTransfusion, 2011
- Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTMTransfusion Medicine and Hemotherapy, 2011
- Limiting and detecting bacterial contamination of apheresis platelets: inlet‐line diversion and increased culture volume improve component safetyTransfusion, 2009
- A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatmentTransfusion, 2008
- Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004‐2006)Transfusion, 2007
- Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopeniaTransfusion, 2006
- Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated setTransfusion, 2005
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialBlood, 2004
- Determinants of transfusion‐associated bacterial contamination: results of the French Bacthem Case‐Control StudyTransfusion, 2001
- Functional Characteristics of S‐59 Photochemically Treated Platelet Concentrates Derived from Buffy CoatsVox Sanguinis, 2000